Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
ZYDUSWELL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Dhaval Narendra Soni, Karta of Dhaval Narendra Soni HUF and Company Secretary of the holding company Zydus Lifesciences Limited, acquired 50 equity shares of Zydus Wellness in the open market on NSE on June 5, 2025. Prior to the acquisition, he held zero shares, and after the purchase his holding stands at 50 shares (0.00%). The total transaction value was approximately Rs. 94,705. The disclosure was filed under SEBI's Prohibition of Insider Trading Regulations as a continual disclosure requirement.
This is a token, routine insider disclosure involving a negligible 50-share purchase (0.00% stake) and has no meaningful impact on the stock price or shareholder wealth. It signals no change in promoter or strategic control of Zydus Wellness.